UBS Turns More Bullish on Gilead Sciences, Inc. (GILD) Amid Positive Pharma Sector Outlook

Gilead Sciences, Inc. (NASDAQ:GILD) is among the most profitable healthcare stocks to buy. On January 26, UBS lifted the terms people connected Gilead Sciences, Inc. (NASDAQ:GILD) from $145 to $155 and maintained a Buy rating, according to TheFly. Slightly beneath the statement 1-year precocious terms target, the revised people implies astir 12% upside.

From appealing valuations and airy positioning to supporting drug-pricing overhangs and sustained pharma-led M&A activity, determination are galore reasons to judge successful the beardown show of the U.S. Pharmaceuticals and Biotechnology group, the expert noted. UBS noted that though determination are worries regarding the blimpish guidance, peculiarly aft the caller rally, inexpensive valuations for large pharma and biotech are expected to proceed affirmative wealth flows into the sector.

Copyright: dolgachov / 123RF Stock Photo

On the aforesaid day, BMO Capital besides raised its people connected Gilead Sciences, Inc. (NASDAQ:GILD) to $150 from $135 and reiterated an Outperform standing connected the stock. While highlighting the Yeztugo launch, which achieved $150 cardinal successful FY25 sales, the steadfast cited beardown momentum successful the company’s HIV business.

​Gilead Sciences, Inc. (NASDAQ:GILD) is simply a California-based biopharmaceutical institution specializing successful medicines aimed astatine unmet needs. Founded successful 1987, the institution provides a scope of products arsenic solutions for HIV/AIDS, COVID-19, viral hepatitis, oncology, pulmonary arterial hypertension, and superior invasive fungal infections.

While we admit the imaginable of GILD arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.